These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 31164161)

  • 21. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.
    Lin Y; Wu Z; Guo W; Li J
    Tumour Biol; 2015 Sep; 36(10):7385-94. PubMed ID: 26364057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic landscape of salivary gland tumors.
    Kato S; Elkin SK; Schwaederle M; Tomson BN; Helsten T; Carter JL; Kurzrock R
    Oncotarget; 2015 Sep; 6(28):25631-45. PubMed ID: 26247885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.
    Østergaard S; Schejbel L; Breinholt MF; Pedersen MØ; Hammer T; Munksgaard L; Nørgaard P; Høgdall E; Gjerdrum LMR; Nielsen TH
    Leuk Lymphoma; 2024 Jun; 65(6):758-767. PubMed ID: 38340359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic mutation analysis of human gastric adenocarcinomas using ion torrent sequencing platform.
    Xu Z; Huo X; Ye H; Tang C; Nandakumar V; Lou F; Zhang D; Dong H; Sun H; Jiang S; Zhang G; Liu Z; Dong Z; Guo B; He Y; Yan C; Wang L; Su Z; Li Y; Gu D; Zhang X; Wu X; Wei X; Hong L; Zhang Y; Yang J; Gong Y; Tang C; Jones L; Huang XF; Chen SY; Chen J
    PLoS One; 2014; 9(7):e100442. PubMed ID: 25025766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between two amplicon-based sequencing panels of different scales in the detection of somatic mutations associated with gastric cancer.
    Hirotsu Y; Kojima Y; Okimoto K; Amemiya K; Mochizuki H; Omata M
    BMC Genomics; 2016 Oct; 17(1):833. PubMed ID: 27782820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
    Furtado LV; Samowitz WS
    Virchows Arch; 2017 Aug; 471(2):235-242. PubMed ID: 28551725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
    Kim HS; Lee H; Shin SJ; Beom SH; Jung M; Bae S; Lee EY; Park KH; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Noh SH; Rha SY; Kim H; Paik S
    Oncotarget; 2017 Jun; 8(24):38389-38398. PubMed ID: 28418920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
    Friedman CF; Ravichandran V; Miller K; Vanderbilt C; Zhou Q; Iasonos A; Vivek M; Mishra P; Leitao MM; Broach V; Sonoda Y; Kyi C; Zamarin D; O'Cearbhaill RE; Konner J; Berger MF; Weigelt B; Momeni Boroujeni A; Park KJ; Aghajanian C; Solit DB; Donoghue MTA
    Clin Cancer Res; 2023 Nov; 29(22):4660-4668. PubMed ID: 37643132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
    Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis by next generation sequencing of gastric type dysplasia occurring in hyperplastic polyps of the stomach: Mutations in gastric hyperplastic polyps.
    Salomao M; Luna AM; Sepulveda JL; Sepulveda AR
    Exp Mol Pathol; 2015 Dec; 99(3):468-73. PubMed ID: 26325218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study.
    Bayle A; Belcaid L; Aldea M; Vasseur D; Peyraud F; Nicotra C; Geraud A; Sakkal M; Seknazi L; Cerbone L; Blanc-Durand F; Hadoux J; Mosele F; Tagliamento M; Bernard-Tessier A; Verret B; Smolenschi C; Clodion R; Auger N; Romano PM; Gazzah A; Camus MN; Micol J; Caron O; Hollebecque A; Loriot Y; Besse B; Lacroix L; Rouleau E; Ponce S; Soria JC; Barlesi F; Andre F; Italiano A
    Ann Oncol; 2023 Apr; 34(4):389-396. PubMed ID: 36709039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer.
    Gao J; Wang H; Zang W; Li B; Rao G; Li L; Yu Y; Li Z; Dong B; Lu Z; Jiang Z; Shen L
    Cancer Sci; 2017 Sep; 108(9):1881-1887. PubMed ID: 28677165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
    Yuen ST; Leung SY
    Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types.
    Shu Y; Wu X; Tong X; Wang X; Chang Z; Mao Y; Chen X; Sun J; Wang Z; Hong Z; Zhu L; Zhu C; Chen J; Liang Y; Shao H; Shao YW
    Sci Rep; 2017 Apr; 7(1):583. PubMed ID: 28373672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
    Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
    Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.